Ribosomal protein L34 pseudogene 29 (RPL34P29)

Ribosomal protein L34 pseudogene 29 (RPL34P29) is classified as a pseudogene within the human genome. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically do not encode a protein product and do not exert an effect in biological pathways. RPL34P29 is named and annotated as a pseudogene related to the ribosomal protein L34 gene family, but unlike protein-coding ribosomal proteins, it does not encode a functional ribosomal protein and has no established biological or disease roles[1][4]. Pseudogenes like RPL34P29 are generally not direct pharmaceutical or diagnostic targets and do not interact with drugs. ### Notes and Justification - **is_target** is **false** because this is a *pseudogene*, not a functional protein or biologically active molecular target[1][4]. - **is_incorrect** is **true** because although the naming matches database conventions, *pseudogenes* like RPL34P29 are not valid therapeutic targets and should not be considered in the same class as receptors, enzymes, or other actionable biomolecules[1]. - There is no evidence of **biological function**, **disease relevance**, **drug interaction**, **mechanism of action**, or **safety concern** associated with this pseudogene[1][4]. - The classification “Other, Pseudogene” reflects that it is neither receptor, transporter, enzyme, nor similar, but instead a non-functional genomic fragment. If a true ribosomal target is intended (e.g., "Ribosomal protein L34"), it should be mapped specifically to the protein-coding gene, not this pseudogene.

Other names

RPL34_15_1483RPL34P29